A detailed history of Stone Run Capital, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Stone Run Capital, LLC holds 3,300 shares of ABT stock, worth $377,223. This represents 0.14% of its overall portfolio holdings.

Number of Shares
3,300
Previous 3,300 -0.0%
Holding current value
$377,223
Previous $343 Million 9.72%
% of portfolio
0.14%
Previous 0.14%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

SELL
$90.19 - $110.4 $63,133 - $77,280
-700 Reduced 17.5%
3,300 $363 Million
Q3 2023

Nov 14, 2023

BUY
$95.53 - $114.62 $382,120 - $458,480
4,000 New
4,000 $387 Million
Q2 2019

Aug 14, 2019

SELL
$72.88 - $85.0 $3,644 - $4,250
-50 Reduced 1.23%
4,000 $337,000
Q3 2018

Nov 14, 2018

BUY
$60.81 - $73.36 $246,280 - $297,108
4,050 New
4,050 $297,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $200B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Stone Run Capital, LLC Portfolio

Follow Stone Run Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stone Run Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Stone Run Capital, LLC with notifications on news.